1. Home
  2. PMVP vs NEPH Comparison

PMVP vs NEPH Comparison

Compare PMVP & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.13

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$4.99

Market Cap

60.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMVP
NEPH
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
60.0M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
PMVP
NEPH
Price
$1.13
$4.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$6.00
AVG Volume (30 Days)
255.3K
63.7K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$34.93
Revenue Growth
N/A
32.36
52 Week Low
$0.81
$1.39
52 Week High
$1.84
$6.42

Technical Indicators

Market Signals
Indicator
PMVP
NEPH
Relative Strength Index (RSI) 33.18 48.21
Support Level $1.14 $4.80
Resistance Level $1.30 $5.97
Average True Range (ATR) 0.07 0.51
MACD -0.01 -0.05
Stochastic Oscillator 2.08 34.82

Price Performance

Historical Comparison
PMVP
NEPH

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: